May 6
Transcelerate RWD Audit Readiness: Data Service Provider Survey – Detailed Report
05/17/2022
The intention of the survey is to help answer: ‘What should sponsors and organizations who provide RWD for research purposes consider when preparing for audits in order to help establish relevance and reliability of RWD in a way that is meaningful to regulatory auditors?’ from the perspective of organizations who provide RWD for research purposes.
Related Blog Posts
More 2026 Clinical Predictions
This is part 2 of my article about predictions for the clinical trials industry in 2026. From my reporting on AI growing pains, site-network shakeups, and the never-ending sponsor–site tension over feasibility and budgets, it’s clear the industry is carrying plenty of unresolved business into the new year. Read the full article featuring Rob DiCicco…
2026 Forecasts From People Smarter Than Me – Part 1
2026 will be defined by uncertainty — geopolitical instability, volatile global markets, and shifting health policies will influence every choice pharma companies make. From clinical trial planning to pipeline priorities, leaders will increasingly weigh innovation against risk, trying to preserve momentum while navigating an unpredictable global landscape. Read the full article featuring Allison Cuff Shimooka…
Nearly a third of clinical trial procedures may not drive results
Clinical trial protocols are among the most complex and resource-intensive documents developed in pharmaceutical and biotechnology research. Designed to define objectives, procedures, participant criteria, and data collection practices, protocols serve as the operational blueprint for evaluating investigational therapies. However, as the range of study endpoints has grown, so too has the volume, complexity, and burden…